Skip to main content

Inspira Technologies Oxy B.H.N. Ltd. (IINN)

New York Stock Exchange Healthcare Medical - DevicesView data quality →
29.1Poor

ValueMarkers Composite Index

Top 0%#44,662 of 44,707
Overvalued

288% above intrinsic value ($0)

UndervaluedFair ValueOvervalued
Piotroski
2/9
Weak
Beneish
-
Altman
-26.88
Distress
DCF Value
$0
Overvalued
ROIC
2.6%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Inspira Technologies Oxy B.H.N. Ltd. (IINN) — VMCI valuation read

Inspira Technologies Oxy B.H.N. Ltd. (IINN) carries a VMCI composite of 29/100, 21 points below the Healthcare sector median of 50. Among mid-cap names, that gap places IINN in the bottom third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The IINN insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads IINN trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of 1.7x is the rate-sensitivity line to watch, the line to track on Inspira Technologies Oxy B.H.N. Ltd.'s next 10-Q.

IINN fell 3.8% over the trailing 7 days, with a -17.2% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in IINN’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.